Amedisys Inc (STU:ADY)
€ 87 0.5 (0.58%) Market Cap: 2.89 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.86 GF Score: 85/100

Amedisys Inc to Discuss the Strategic Rationale of the Contessa Health Acquisition - M&A Call Transcript

Jun 30, 2021 / 11:00PM GMT
Operator

Greetings, and welcome to the Amedisys' investor call to discuss the signing of the Contessa acquisition. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Nick Muscato. Thank you, Nick. You may begin.

Nick Muscato
Amedisys, Inc. - SVP of Finance

Thank you, operator, and welcome to the Amedisys investor conference call to discuss our signing of the definitive agreement to acquire Contessa Health. A copy of our press release, supplemental slides and related Form 8-K filing with the SEC are available on the Investor Relations page of our website.

Speaking on today's call from Amedisys will be Paul Kusserow, Chairman and Chief Executive Officer; and from Contessa, Founder and Chief Executive Officer, Travis Messina. Also joining us is Chris Gerard, President and Chief Operating Officer; Scott Ginn, Executive Vice President and Chief Financial Officer; and Dave Kemmerly, Chief Legal and Government Affairs Officer.

Before we get started with our call, I would like to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot